MILLENNIUM MANAGEMENT LLC - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 45 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$207,000
+21.8%
836,876
+155.2%
0.00%–
Q2 2022$170,000
+100.0%
327,968
+1501.1%
0.00%–
Q4 2021$85,000
-54.5%
20,484
+1.9%
0.00%–
Q3 2021$187,000
-74.0%
20,100
-49.6%
0.00%–
Q2 2021$718,000–39,893–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q2 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders